CL

Colgate-Palmolive Co. stock has experienced a decline of 3.82% over the past year. In Q4 2025, the company reported a GAAP net loss, but generated significant revenue and free cash flow for the full fiscal year. Q1 2026 saw sales growth, but EPS declined. The company announced an acceleration of a multi-year Strategic Growth and Productivity Program. Analyst sentiment for CL is generally a "Moderate Buy," with an average 12-month price target of approximately $95.56. Insider selling has also been noted.